archiveHEA

Investing

Novo Nordisk invests $6 bln in Wegovy production, still far below demand -CEO

The logo of Danish drugmaker Novo Nordisk, Copenhagen, Denmark, September 26, 2023. REUTERS/Tom Little/File Photo Acquire Licensing RightsLONDON/COPENHAGEN, Nov 10 (Reuters) - Obesity drug maker Novo Nordisk (NOVOb.CO) said on Friday it will spend $6 billion to boost production in Denmark, although its chief executive warned the industry was far from being able to produce enough weight-loss drugs to meet global demand.Novo Nordisk has had phenomenal success with its anti-obesity drug, Wegovy, but has scrambled to address shortages that have forced it to limit the number of patients.The World Health...
Banking

Israel rebuffs calls for ceasefire; Lebanon strike angers Hezbollah

LATEST DEVELOPMENTS:Hezbollah says response will be 'firm and strong' after strike kills 3 children in LebanonBlinken says Palestinian Authority should have central role in future of GazaPalestinian telecommunications company Paltel says communications, internet service cut again across GazaGAZA/RAMALLAH, Nov 5 (Reuters) - Israel on Sunday rebuffed growing international pressure for a ceasefire and said its forces had encircled Gaza City as the top U.S. diplomat scrambled to contain a crisis that threatened to cause further escalation in neighbouring Lebanon.Gaza was under "unprecedented bombardment" from Israel on Sunday, Palestinian news agency...
1 2 3 4 9
Page 2 of 9